On : 08 April 2024



• The Global Pre-Implantation Genetic Diagnosis (PGD) Market Size was estimated at USD 106.72 million in 2023 and is projected to reach USD 137.39 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.


On : 08 April 2024
• The Global Pre-Implantation Genetic Diagnosis (PGD) Market Size was estimated at USD 106.72 million in 2023 and is projected to reach USD 137.39 million by 2029, exhibiting a CAGR of 4.30% during the forecast period.
• Pre-Implantation Genetic Diagnosis (PGD) is the genetic profiling of embryos prior to implantation (as a form of embryo profiling), and sometimes even of oocytes prior to fertilization.
• Pre-Implantation Genetic Diagnosis Market provides a deep insight into the global Pre-Implantation Genetic Diagnosis (PGD) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.